Evidence map›Paper›PMID 36685570›Full record

ArticleFrontiers in immunology2022

Corrigendum: Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance.

Mariko Shirane, Nobuyo Yawata, Daisuke Motooka, Kensuke Shibata, Seik-Soon Khor, Yosuke Omae, Toshikatsu Kaburaki, Ryoji Yanai, Hisashi Mashimo, Satoshi Yamana and 18 more

Abstract readPublished Erratum
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Mariko ShiraneDepartment of Ophthalmology, Kyushu University, Fukuoka, Japan.
Nobuyo YawataDepartment of Ocular Pathology and Imaging Science, Kyushu University, Fukuoka, Japan.
Daisuke MotookaDepartment of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Kensuke ShibataDepartment of Ocular Pathology and Imaging Science, Kyushu University, Fukuoka, Japan.
Seik-Soon KhorGenome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan.
Yosuke OmaeGenome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan.
Toshikatsu KaburakiDepartment of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan.
Ryoji YanaiDepartment of Ophthalmology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Hisashi MashimoDepartment of Ophthalmology, Japan Community Health Care Organization Hospital, Osaka, Japan.
Satoshi YamanaDepartment of Ophthalmology, Kyushu University, Fukuoka, Japan.
Takako ItoDepartment of Ophthalmology, Kyushu University, Fukuoka, Japan.
Akira HayashidaDepartment of Ophthalmology, Kyushu University, Fukuoka, Japan.
Yasuo MoriDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
Akihiko NumataDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
Yusuke MurakamiDepartment of Ophthalmology, Kyushu University, Fukuoka, Japan.
Kohta FujiwaraDepartment of Ophthalmology, Kyushu University, Fukuoka, Japan.
Nobuyuki OhguroDepartment of Ophthalmology, Japan Community Health Care Organization Hospital, Osaka, Japan.
Mayumi HosogaiDepartment of Ophthalmology, Gunma University Graduate School of Medicine, Gunma, Japan.
Masato AkiyamaDepartment of Ocular Pathology and Imaging Science, Kyushu University, Fukuoka, Japan.
Eiichi HasegawaDepartment of Ophthalmology, Kyushu University, Fukuoka, Japan.
Michael PaleyDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
Atsunobu TakedaDepartment of Ophthalmology, Kyushu University, Fukuoka, Japan.
Katsumi MaenakaCenter for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Koichi AkashiDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
Wayne M YokoyamaDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
Katsushi TokunagaGenome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan.
Makoto YawataSingapore Institute for Clinical Sciences (SICS), Agency for Science, Technology and Research, ASTAR, Singapore, Singapore.
Koh-Hei SonodaDepartment of Ophthalmology, Kyushu University, Fukuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.1008220.].

Indexed as

CMV retinitisCMV viremiaHLA class IHLA-Ehuman cytomegalovirusnatural killer cellsNKG2AUL40

Identifiers

PMID36685570
PMCPMC9851041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.